BackAtara Biotherapeutics Overview

Atara Biotherapeutics Net Tangible Assets

Atara Biotherapeutics's net tangible assets is $-37M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$-37.31M

Peer average

Loading

Atara Biotherapeutics Net Tangible Assets History

Loading

Atara Biotherapeutics vs. peers: Net Tangible Assets Comparison

Loading

Atara Biotherapeutics Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Atara Biotherapeutics (ATRA) FAQ

As of the most recent data (March 2026), ATRA shows a net tangible assets of $-37M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ATRA's net tangible assets is now $-37M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Atara Biotherapeutics is outperforming or lagging.

Tracking ATRA's net tangible assets over time shows whether Atara Biotherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $-37M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Atara Biotherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $-37M) with ownership activity and broader fundamentals.

Atara Biotherapeutics's net tangible assets is $-37M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.